Medication-assisted treatment in Maine

Medication-assisted treatment in Augusta and Sanford, Maine.

Suboxone® strips and tablets, Subutex®, Sublocade®, Brixadi®, and oral naltrexone are well-studied medications that treat opioid use disorder and alcohol use disorder so the rest of your life can grow back. We prescribe, we monitor, and we pair them with weekly therapy and case management under one clinical team.

Maine outpatient clinic client in soft window light facing the provider across a simple wood desk during a calm MAT consultation, over-the-shoulder view past the provider.
What MAT is

How medication-assisted treatment actually works.

MAT consists of two things working together: medication that treats addiction, and therapy and case management that let you rebuild your life. The medication keeps cravings and withdrawal from running the day. Your therapist, your medical provider, and your case manager work with you on the rest.

Buprenorphine is the active ingredient in Suboxone®, Subutex®, Sublocade®, and Brixadi®. It works on the same brain receptors as opioids like oxycodone or heroin, but it caps out at a safe level instead of climbing higher. Doctors call that a partial agonist with a ceiling effect. The cap is what eases withdrawal and cravings without producing the high a person can chase, and it’s what makes the medication dramatically safer than the alternatives. Oral naltrexone works a different way, blocking opioid and alcohol receptors entirely as a daily non-opioid tablet so alcohol and opioids do not feel rewarding.

Enso is MARR-certified (Maine Association of Recovery Residences) and operates outpatient clinics in Augusta and Sanford. Our MAT provider writes the prescriptions. Our licensed therapists hold the weekly sessions. Our case managers handle the practical work around identification, housing, and benefits. One team, under one roof, with one plan.

Leading medical bodies

The American Medical Association, the American Society of Addiction Medicine, and the National Institute on Drug Abuse all classify MAT as the standard of care for opioid use disorder. The evidence on retention, overdose prevention, and long-term recovery is consistent across decades of research.

Coordinated prescribing

Our MAT prescriber sees clients on Tuesdays alongside weekly counseling and case management. Meet our clinical leadership on the About page.

The medicines we prescribe

Suboxone, Subutex, Sublocade, Brixadi, and oral naltrexone.

About 40% of our MAT clients are on a long-acting injectable. Once a client stabilizes on oral buprenorphine, our provider writes the injectable prescription and coordinates partner administration so daily pill bottles leave the picture.

Open paper monthly desk calendar on a warm wood desk in a Maine outpatient clinic consult room with one date lightly pencil-circled, a black ballpoint pen alongside, and a stoneware mug out of focus in soft afternoon window light.
Sublingual strips or tablets, daily

Suboxone® / Subutex®

Buprenorphine, with or without naloxone

The most common starting point for MAT. Suboxone combines buprenorphine with naloxone as a daily sublingual strip (film) or tablet that dissolves under the tongue, easing withdrawal and cravings while discouraging misuse. Subutex (buprenorphine without naloxone) is prescribed when clinically indicated, including during pregnancy.

Monthly injectable

Sublocade®

Buprenorphine extended-release

One monthly injection instead of a daily routine. Once you are stable on oral buprenorphine, our MAT provider writes the prescription for Sublocade and coordinates administration through MaineGeneral or another local medical partner. It releases buprenorphine steadily for 28 to 30 days so you are not thinking about medication between visits.

Weekly or monthly injectable

Brixadi®

Buprenorphine extended-release

An extended-release buprenorphine option available in weekly or monthly doses. Once our provider confirms oral buprenorphine tolerance and dosing, Enso writes the prescription and coordinates administration with a local medical partner while managing your ongoing care here.

Oral tablet, daily

Oral Naltrexone

Naltrexone hydrochloride

A non-opioid daily tablet prescribed for alcohol use disorder or for opioid relapse prevention once detox is complete. Naltrexone blocks alcohol and opioid receptors to reduce cravings and the reward response. For opioid use disorder, clients must be opioid-free for 7 to 10 days before starting.

Who MAT is for

MAT is right for you if any of this sounds familiar.

You don’t have to hit bottom first and you don’t have to have insurance figured out.

You’re dealing with opioid use disorder and want to stop.

You’ve tried to stop on your own or through short-term detox and it has not held.

You’re coming back from county jail and need continuity of medication on the outside.

You have MaineCare, Medicare, or no insurance at all.

A family member, referring provider, or court pushed you toward treatment.

You’ve felt discharged from another program on somebody else’s timeline.

You’ve used Suboxone® on the street and want a medically managed prescription.

You want to rebuild work, housing, and family without withdrawal running the day.

How MAT starts

What to expect when you call.

From your first screening call to your provider visit, our clinical team reviews every inquiry promptly and moves as fast as clinical safety allows.

01

Call or send a message.

Admissions answers Monday through Friday, 8:00 AM to 4:30 PM to complete your initial screening and verify MaineCare, Medicare, OHH, STR, or sliding-scale options.

02

Clinical review and assessment.

Your screening is sent to program leadership and our clinical team to review and assess eligibility and confirm Enso is a safe, appropriate setting for your care.

03

Accepted and connected to care.

Once accepted into the program, you meet your outpatient therapist or start daily structured IOP group alongside your case manager to build your treatment plan.

04

MAT provider visits on Tuesdays.

Meet our MAT prescriber on Tuesdays to begin Suboxone® or Subutex®. Once stable on oral buprenorphine, our provider can prescribe Sublocade® or Brixadi® for partner administration.

Insurance and cost

MaineCare and Medicare cover MAT, with funding paths if you are uninsured.

MaineCare (Maine’s Medicaid program) covers medication-assisted treatment in full, including long-acting injectables. Medicare covers MAT and long-acting injectables under behavioral health and Part B benefits.

If you are uninsured, we work with OHH (Opioid Health Homes) funding, STR (State Targeted Response) grant funding, or a sliding fee scale based on income. Nobody is turned away for financial reasons.

Common questions about MAT

Questions about MAT at Enso.

No. Buprenorphine and oral naltrexone are not the same as full-agonist opioids like oxycodone, heroin, or fentanyl. Buprenorphine works on the same brain receptors as those drugs, but it caps out at a safe level instead of climbing higher. That ceiling effect eases withdrawal and cravings without producing the high a person can chase. Oral naltrexone is a non-opioid tablet that blocks the receptors entirely. The AMA, ASAM, and NIDA all classify MAT as the standard of care.

As long as it keeps you in recovery. Some clients stay on MAT for a year. Some stay for many years. Some taper off under medical supervision. We do not run a built-in clock on your medication. Discharge is driven by the client’s situation, not the program’s schedule.

For buprenorphine (Suboxone® strips or tablets, Subutex®, Sublocade®, Brixadi®), you need to be in moderate withdrawal before the first dose to prevent precipitated withdrawal, usually 12 to 24 hours after your last short-acting opioid. For oral naltrexone in opioid use disorder, you need to be opioid-free for 7 to 10 days first (while for alcohol use disorder without opioids, oral naltrexone can begin without an opioid washout). Our MAT provider walks you through the timing carefully.

You start with an admissions screening that is reviewed and assessed by our clinical team to confirm program fit. Once accepted, you meet your counselor (individual outpatient or daily structured IOP group) and your case manager to address practical needs like ID, housing, insurance, and transportation, and you meet our MAT prescriber on Tuesdays to begin medication management.

Standard 5-panel drug tests do not detect buprenorphine. Expanded panels can. If it does show up, it is a legally prescribed medication. A medical review officer verifies the prescription and the result is reported as negative for cause. We provide documentation for your employer or licensing board on request.

Yes. MaineCare covers MAT in full, including long-acting injectables. You will not pay out-of-pocket for medication or office visits on a MaineCare plan in good standing. Our case managers handle the billing and any prior-authorization steps.

We keep you in treatment. A relapse is clinical information, not a reason for discharge. Your plan adjusts: more frequent visits, a medication change, additional therapy, or help addressing the stressor that triggered the relapse. We do not discharge people for relapsing.

Yes, and many clients do. Our provider first makes sure you are stable on oral buprenorphine so tolerance and dosing are confirmed. Once stable, our provider writes the prescription for Sublocade or Brixadi and coordinates with MaineGeneral or another local medical partner that administers the injection.

Start MAT

Starting takes less time than you think.

The form takes a couple of minutes. Admissions completes your screening, verifies coverage, and once accepted gets you scheduled with your counselor and our Tuesday MAT prescriber. MaineCare accepted, no referral required.